Detalhe da pesquisa
1.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Lancet Oncol
; 25(2): 255-264, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142702
2.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405085
3.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
4.
Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression.
Histopathology
; 81(2): 228-238, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562857
5.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 22(4): 463-475, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684370
6.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med
; 379(5): 417-427, 2018 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860937
7.
Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab.
Int J Clin Oncol
; 26(11): 2087-2093, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338919
8.
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Int J Cancer
; 146(6): 1643-1651, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318983
9.
Immunotherapy in Renal Cell Carcinoma: The Future Is Now.
Int J Mol Sci
; 21(7)2020 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32260578
10.
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
N Engl J Med
; 375(23): 2246-2254, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718781
11.
Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study.
BJU Int
; 123(5): 804-810, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288884
12.
Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma.
Int J Mol Sci
; 20(7)2019 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987368
13.
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.
Acta Oncol
; 57(4): 498-508, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29095068
14.
[Low-grade eosinophilic unclassified renal cell carcinoma, a recently proposed entity in the spectrum of eosinophilic renal cells tumors: Report of one case and discussion]. / Le carcinome rénal inclassé de bas grade à cellules éosinophiles, une entité récemment proposée dans le spectre des tumeurs rénales à cellules éosinophiles : étude d'un cas et discussion.
Ann Pathol
; 38(6): 395-400, 2018 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-30077423
15.
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.
Int J Cancer
; 140(1): 142-148, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27623354
16.
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study.
BMC Cancer
; 17(1): 355, 2017 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28532444
17.
A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France.
Support Care Cancer
; 25(7): 2055-2062, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188447
18.
Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma.
BJU Int
; 117(3): 444-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601543
19.
Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept.
World J Urol
; 39(9): 3707-3709, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632555
20.
Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
Int J Urol
; 23(10): 840-846, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27416787